Cargando…
1380. Safety of Repurposed Drugs for Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: An Analysis of Adverse Events Reported in the Literature
BACKGROUND: Multi and extensively drug-resistant (MDR and XDR) tuberculosis (TB) remains a treatment challenge due to drug adverse events (AEs) and long regimens. Our aim was to identify AEs which resulted from repurposing drugs for MDR and XDR-TB. METHODS: A PubMed search for case reports of repurp...
Autores principales: | Stone, Heather, Duggal, Mili, Sacks, Leonard, Ghosh, Mayurika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809250/ http://dx.doi.org/10.1093/ofid/ofz360.1244 |
Ejemplares similares
-
New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2018) -
546. Capturing Clinician’s Experiences Repurposing Drugs to Inform Future Studies During COVID-19
por: Duggal, Mili, et al.
Publicado: (2020) -
Collaborative Use Repurposing Engine (CURE): FDA-NCATS/NIH Effort to Capture the Global Clinical Experience of Drug Repurposing to Facilitate Development of New Treatments for Neglected and Emerging Infectious Diseases
por: Stone, Heather, et al.
Publicado: (2017) -
Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany
por: Eker, Barbara, et al.
Publicado: (2008) -
Clonal Expansion of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis, Japan
por: Murase, Yoshiro, et al.
Publicado: (2010)